|
1
|
Phillipson M and Kubes P: The neutrophil
in vascular inflammation. Nat Med. 17:1381–1390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Popović M, Smiljanić K, Dobutović B,
Syrovets T, Simmet T and Isenović ER: Thrombin and vascular
inflammation. Mol Cell Biochem. 359:301–313. 2012. View Article : Google Scholar
|
|
3
|
Lindbom L: Regulation of vascular
permeability by neutrophils in acute inflammation. Chem Immunol
Allergy. 83:146–166. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aghajanian A, Wittchen ES, Allingham MJ,
Garrett TA and Burridge K: Endothelial cell junctions and the
regulation of vascular permeability and leukocyte transmigration. J
Thromb Haemost. 6:1453–1460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vestweber D: VE-cadherin: The major
endothelial adhesion molecule controlling cellular junctions and
blood vessel formation. Arterioscler Thromb Vasc Biol. 28:223–232.
2008. View Article : Google Scholar
|
|
6
|
Van Itallie CM and Anderson JM:
Architecture of tight junctions and principles of molecular
composition. Semin Cell Dev Biol. 36:157–165. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang Z, An LJ, Duan YL, Li YC and Jiang B:
Catalpol protects rat pheochromocytoma cells against oxygen and
glucose deprivation-induced injury. Neurol Res. 30:106–112. 2008.
View Article : Google Scholar
|
|
8
|
Zhang X, Jin C, Li Y, Guan S, Han F and
Zhang S: Catalpol improves cholinergic function and reduces
inflammatory cytokines in the senescent mice induced by
D-galactose. Food Chem Toxicol. 58:50–55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fu K, Piao T, Wang M, Zhang J, Jiang J,
Wang X and Liu H: Protective effect of catalpol on
lipopolysaccharide-induced acute lung injury in mice. Int
Immunopharmacol. 23:400–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu YR, Li PW, Suo JJ, Sun Y, Zhang BA, Lu
H, Zhu HC and Zhang GB: Catalpol provides protective effects
against cerebral ischaemia/reperfusion injury in gerbils. J Pharm
Pharmacol. 66:1265–1270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tian YY, An LJ, Jiang L, Duan YL, Chen J
and Jiang B: Catalpol protects dopaminergic neurons from
LPS-induced neurotoxicity in mesencephalic neuron-glia cultures.
Life Sci. 80:193–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong J, Kandasamy K, Marimuthu M, Choi CS
and Kim S: Electrical cell-substrate impedance sensing as a
non-invasive tool for cancer cell study. Analyst. 136:237–245.
2011. View Article : Google Scholar
|
|
13
|
Wallez Y and Huber P: Endothelial adherens
and tight junctions in vascular homeostasis, inflammation and
angiogenesis. Biochim Biophys Acta. 1778:794–809. 2008. View Article : Google Scholar
|
|
14
|
Yuan L, Le Bras A, Sacharidou A, Itagaki
K, Zhan Y, Kondo M, Carman CV, Davis GE, Aird WC and Oettgen P:
ETS-related gene (ERG) controls endothelial cell permeability via
transcriptional regulation of the claudin 5 (CLDN5) gene. J Biol
Chem. 287:6582–6591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li DQ, Bao YM, Li Y, Wang CF, Liu Y and An
LJ: Catalpol modulates the expressions of Bcl-2 and Bax and
attenuates apoptosis in gerbils after ischemic injury. Brain Res.
1115:179–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bi J, Jiang B, Zorn A, Zhao RG, Liu P and
An LJ: Catalpol inhibits LPS plus IFN-gamma-induced inflammatory
response in astrocytes primary cultures. Toxicol In Vitro.
27:543–550. 2013. View Article : Google Scholar
|
|
17
|
Bi J, Jiang B, Liu JH, Lei C, Zhang XL and
An LJ: Protective effects of catalpol against H2O2-induced
oxidative stress in astrocytes primary cultures. Neurosci Lett.
442:224–227. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hordijk PL, Anthony E, Mul FP, Rientsma R,
Oomen LC and Roos D: Vascular-endothelial-cadherin modulates
endothelial monolayer permeability. J Cell Sci. 112:1915–1923.
1999.PubMed/NCBI
|
|
19
|
Dejana E and Giampietro C: Vascular
endothelial-cadherin and vascular stability. Curr Opin Hematol.
19:218–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gavard J: Breaking the VE-cadherin bonds.
FEBS lett. 583:1–6. 2009. View Article : Google Scholar
|
|
21
|
Yuan SY: Protein kinase signaling in the
modulation of micro-vascular permeability. Vascul Pharmacol.
39:213–223. 2002. View Article : Google Scholar
|
|
22
|
Dong F, Guo F, Li L, Guo L, Hou Y, Hao E,
Yan S, Allen TD and Liu J: Cadmium induces vascular permeability
via activation of the p38 MAPK pathway. Biochem Biophys Res Commun.
450:447–452. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prandini MH, Dreher I, Bouillot S,
Benkerri S, Moll T and Huber P: The human VE-cadherin promoter is
subjected to organ-specific regulation and is activated in tumour
angiogenesis. Oncogene. 24:2992–3001. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu HF, Wan D, Luo Y, Zhou JL, Chen L and
Xu XY: Catalpol increases brain angiogenesis and up-regulates VEGF
and EPO in the rat after permanent middle cerebral artery
occlusion. Int J Biol Sci. 6:443–453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dvorak HF: VPF/VEGF and the angiogenic
response. Semin Perinatol. 24:75–78. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hebda JK, Leclair HM, Azzi S, Roussel C,
Scott MG, Bidère N and Gavard J: The C-terminus region of
β-arrestin1 modulates VE-cadherin expression and endothelial cell
permeability. Cell Commun Signal. 11:372013. View Article : Google Scholar
|
|
27
|
Gavard J and Gutkind JS: VEGF controls
endothelial-cell permeability by promoting the
beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol.
8:1223–1234. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Esser S, Lampugnani MG, Corada M, Dejana E
and Risau W: Vascular endothelial growth factor induces VE-cadherin
tyrosine phosphorylation in endothelial cells. J Cell Sci.
111:1853–1865. 1998.PubMed/NCBI
|
|
29
|
Oettgen P: Regulation of vascular
inflammation and remodeling by ETS factors. Circ Res. 99:1159–1166.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sperone A, Dryden NH, Birdsey GM, Madden
L, Johns M, Evans PC, Mason JC, Haskard DO, Boyle JJ, Paleolog EM
and Randi AM: The transcription factor Erg inhibits vascular
inflammation by repressing NF-kappaB activation and proinflammatory
gene expression in endothelial cells. Arterioscler Thromb Vasc
Biol. 31:142–150. 2011. View Article : Google Scholar
|
|
31
|
Yuan L, Nikolova-Krstevski V, Zhan Y,
Kondo M, Bhasin M, Varghese L, Yano K, Carman CV, Aird WC and
Oettgen P: Antiinflammatory effects of the ETS factor ERG in
endothelial cells are mediated through transcriptional repression
of the interleukin-8 gene. Circ Res. 104:1049–1057. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu J, Yuan L, Molema G, Regan E, Janes L,
Beeler D, Spokes KC, Okada Y, Minami T, Oettgen P and Aird WC:
Vascular bed-specific regulation of the von Willebrand factor
promoter in the heart and skeletal muscle. Blood. 117:342–351.
2011. View Article : Google Scholar :
|
